Shilfenib 200mg Tablet

Prezentare produs

About Shilfenib

Shilfenib is a medication containing the active ingredient Sorafenib, classified as Kinase Inhibitor. Sorafenib, sold under the brand name Nexavar, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.

Key Benefits & Uses

• Used for: Sorafenib tablets are a kinase inhibitor indicated for the treatment of Unresectable hepatocellular carcinoma(1
• Used for: 1) Locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DTC) refractory to radioactive iodine treatment (1
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Sorafenib, the active ingredient in Shilfenib, belongs to the Kinase Inhibitor class. Sorafenib tablets are a kinase inhibitor indicated for the treatment of Unresectable hepatocellular carcinoma(1. 1) Locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DTC) refractory to radioactive iodine treatment (1. 3) 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Shilfenib. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Shilfenib for extended periods without medical advice.